COMPARISON OF IBI AND PBI CALCULATED FOR 68GA-PSMA AND 18F-FDG IN MULTIPLE MYELOMA PATIENTS

COMPARISON OF IBI AND PBI CALCULATED FOR 68GA-PSMA AND 18F-FDG IN MULTIPLE MYELOMA PATIENTS

Introduction/Justification: The benefits of using 18F-FDG PET/CT for staging and managing treatment in patients with multiple myeloma (MM) are extensively documented. Recent studies indicate that 68Ga-PSMA PET/CT is also an excellent marker for MM lesions and may complement 18F-FDG due to the signif...

Full description

Bibliographic Details
Main Authors: Maria Emilia Seren Takahashi, Stephan P.M. Souza, Fernanda C. Frasson, Gislaine B. Oliveira, Vania P. Castro, Fernando V. Pericole, Lício A. Velloso, Cármino A. Souza, Irene G.H. Lorand-Metze, Allan O. Santos, Celso Darío Ramos
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
FDG
IBI
multiple myeloma
PSMA
Online Access:http://www.sciencedirect.com/science/article/pii/S253113792400169X

Internet

http://www.sciencedirect.com/science/article/pii/S253113792400169X

Similar Items